ACP Healthtech is a Frankfurt am Main-based venture capital firm and AIFM-regulated fund investing in healthtech and medtech companies at regulatory and commercial inflection points. It targets B2B healthtech, AI-enabled diagnostics, smart medtech, techbio, medical devices and robotics, with focus around FDA/MDR milestones, and has acted as a lead investor. The firm is relevant for pre-seed and seed opportunities, with a mandate spanning Europe, Germany, the United States and the Middle East.